购物车
- 全部删除
- 您的购物车当前为空
iNOS/TopoI-IN-1(compound AuL9)是一种具备多重靶点的杂交分子,表现出抗肿瘤、抗炎及抗氧化的特性。此化合物能有效抑制乳腺癌细胞株MCF-7和MDA MB-231的增长,IC50分别为3.5 μM及6.3 μM,其机制主要是通过抑制人类拓扑异构酶I(TopoI)(Ki=2.72 μM)的活动,导致DNA损伤并诱发细胞凋亡(apoptosis)。同时,iNOS/TopoI-IN-1通过降低NF-kB的激活,抑制iNOS表达(Ki=1.49 μM),进一步增强其抗炎作用。
iNOS/TopoI-IN-1(compound AuL9)是一种具备多重靶点的杂交分子,表现出抗肿瘤、抗炎及抗氧化的特性。此化合物能有效抑制乳腺癌细胞株MCF-7和MDA MB-231的增长,IC50分别为3.5 μM及6.3 μM,其机制主要是通过抑制人类拓扑异构酶I(TopoI)(Ki=2.72 μM)的活动,导致DNA损伤并诱发细胞凋亡(apoptosis)。同时,iNOS/TopoI-IN-1通过降低NF-kB的激活,抑制iNOS表达(Ki=1.49 μM),进一步增强其抗炎作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | Compound AuL9, also known as iNOS/TopoI-IN-1, is a multi-target hybrid molecule possessing anti-tumor, anti-inflammatory, and antioxidant properties. This compound effectively inhibits the growth of MCF-7 and MDA MB-231 breast cancer cells in vitro, exhibiting IC50 values of 3.5 μM and 6.3 μM respectively. It also prompts DNA damage and apoptosis in these cells by inhibiting human topoisomerase I (TopoI) with a K_i of 2.72 μM. Additionally, iNOS/TopoI-IN-1 reduces the expression of iNOS by suppressing the activation of NF-kB, with a K_i of 1.49 μM. |
靶点活性 | iNOS:1.49 μM (Ki), Topoisomerase I:2.72 μM (Ki) |
分子量 | 886.54 |
分子式 | C34H40AuBrCl2N3OS |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.